Merck's Appeal In Vioxx Case Likely To Focus On Expert Testimony, Evidentiary Rulings
This article was originally published in The Pink Sheet Daily
Executive Summary
In the first Vioxx product liability case to reach trial, a Texas jury awards the plaintiff $253.5 mil. in damages, the bulk of which are punitive damages that would be capped under state law.
You may also be interested in...
Win, Lose & Draw: Third Merck Vioxx Trial Ends In Mistrial
A Houston jury was unable to reach a verdict in the first federal product liability trial over the COX-2 inhibitor.
Win, Lose & Draw: Third Merck Vioxx Trial Ends In Mistrial
A Houston jury was unable to reach a verdict in the first federal product liability trial over the COX-2 inhibitor.
Merck Cleared In Second Vioxx Product Liability Case
Atlantic City, N.J. state court verdict clears Merck of allegations the drug maker failed to warn patients of risks associated with the use of Vioxx.